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Abstract
Aims/hypothesis We wanted to identify a five-item short form 
of the Problem Areas in Diabetes Scale and a single-item 
measure for rapid screening of diabetes-related emotional 
distress.
Methods Using an existing database of 1,153 patients with 
diabetes, we conducted a principal-components analysis to 
identify a set of five items and then conducted a reliability 
analysis and validity checks. From those five items, we 
identified the item with the strongest psychometric properties 
as a one-item screening tool.
Results We identified a reliable and valid short version 
of the Problem Areas in Diabetes Scale (PAID) 
comprising five of the emotional-distress questions of 
the full PAID items (PAID-5, with items 3, 6, 12, 16, 
19). The PAID-5 has satisfactory sensitivity (94%) and 
specificity (89%) for recognition of diabetes-related 
emotional distress. We also identified a one-item 
screening tool, the PAID-1 (Question 12: Worrying 
about the future and the possibility of serious compli­
cations), which has concurrent sensitivity and specificity 
of about 80% for the recognition of diabetes-related 
emotional distress.
Concliisions/interpretation The PAID-5 and PAID-1 appear 
to be psychometrically robust short-form measures of 
diabetes-related emotional distress.
Electronic supplementary material The online version of this article 
(doi: 10.1007/s00125-009-1559-5) contains supplementary material, 
which is available to authorised users.
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Abbreviations
EFA Exploratory factor analysis
PAID Problem Areas in Diabetes Scale
PAID-1 Problem Areas in Diabetes Scale—One-item
Screening Form
PAID-5 Problem Areas in Diabetes Scale—Five-item 
Short Form
WHO-5 WHO Five Item Measure of Wellbeing
The prevalence of serious psychological distress in people 
with diabetes is significant and contributes to disease- 
related burden [1]. Consequently, international guidelines 
advocate routine screening for psychological problems 
[2, 3]. The Problem Areas in Diabetes Scale (PAID) [4] 
has been recommended for identifying depression and 
diabetes-related distress [5]. The PAID is a widely used 
measure, containing 20 items which have a five-point 
response option (0-4 representing ‘Not a problem’ through 
to ‘Serious problem’). The PAID has four factors or 
dimensions measuring diabetes-related emotional problems 
(12 questions), treatment-related problems (three ques­
tions), food-related problems (three questions), and social 
support-related problems (two questions). The PAID has 
been translated into various languages, is widely employed 
to monitor change following an intervention and its 
psychometric properties have been established [6, 7]. 
However, while clinically useful, wider use of the PAID 
may be limited by its length.
Recently, a two-item screening version of the Diabetes 
Distress Scale (DDS) was validated and showed good 
sensitivity (95%) and specificity (85%) [8]. However, as 
the PAID remains a more widely used instrument, we 
aimed to develop a five-item short form for routine 
clinical and research use and a single-item measure that 
may be used as a rapid screen for diabetes-related 
emotional distress.
Methods
Participants Our sample comprised 1,153 respondents to 
the PAID from an ongoing international, multicentre study 
of psychosocial care in diabetes (Diabetes Attitudes Wishes 
and Needs [DAWN] Monitoring Individual Needs in 
Diabetes [MIND] study) [9]. Data on well-being (WHO 
Five Item Measure of Wellbeing [WHO-5] ) and on various 
demographic and biomedical variables are also included.
The average age of respondents was 53.8 years (SD= 
14.7; range-18—89), 601 (52.1%) were women, and most 
were employed full-time (36.8%, 77=424) or retired (26.4%, 
77=304). A majority: had type 2 diabetes (63.2%, 77=729); 
reported having diabetes for 11 years or longer (52.6%, 77= 
607); had no episodes of hypoglycaemia (78.1%, 77=901 ); 
and, in terms of treatment, were using insulin (49.6%, n = 
572) or oral glucose-lowering agents (28.1%, 77=324). 
Finally, 54.9% (77=601) of participants reported no 
diabetes-related complications, 24.7% (77=270) reported 
having one complication, and 20.4% (77=223) reported 
having two or more complications.
Procedure To identity a short-form version of the PAID, 
two subsamples were randomly created (,7=589 and „=564). 
No statistically significant differences between the subsam­
ples were noted on the variables of age, sex composition, 
type of diabetes, glycosylated haemoglobin level, work 
status, complication frequency status and average WHO-5 
scores. Thus, the random division produced comparable 
groups of participants.
Results
Five-item short form For subgroup 1, we conducted a 
principal-components analysis, which is an item-reduction 
technique, and found a one-component solution. Ten items 
loaded above 0.50, all of which were from the Diabetes- 
related Negative Emotions subscale (items 3, 6, 7, 8, 9, 10, 
12, 16, 19, 20). We removed three items rated on average 
by respondents as less than a ‘minor problem’ (items 8, 10, 
20) and the remaining seven items were subjected to a 
reliability analysis. The two items which correlated most 
poorly with the other items were removed, resulting in a 
five-item short-form version (items 3, 6, 12, 16, 19—see 
Electronic Supplementary Material [ESM]). Cronbach’s 
alpha, a measure of the reliability or correlation between 
items in a test, was good (see Table 1). Total scores on the 
PAID-5 can range from 0 to 20, with higher scores 
suggesting greater diabetes-related emotional distress. For 
subsample 1, the average score was 6.07 (SD=5.09; range 
0-20).
The PAID-5 total score correlated significantly with the 
PAID-20 total score, r=0.92, /?<0.001. The validity of the 
PAID-5 was also demonstrated by a statistically significant 
correlation with a measure of well-being (the WHO-5), 
r=-0.47, p<0.001. The direction of this correlation 
suggests that as diabetes-related distress increases, well­
being decreases. Correlations between the PAID-5 and the 
other subscales of the PAID (treatment-related problems; 
food-related problems; lack of social support) were also 
investigated. Consistent with research suggesting that 
different aspects of diabetes-related distress are interrelated,
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Table 1 Scale score reliability 
for all measures Measure Cronbach’s a (95% CI)
Subsample 1 (n=589) Subsample 2 (n=564)
PAID-5 0.86 (0.84-0.88) 0.83 (0.80-0.85)
PAID-Treatment problems 0.67 (0.63-0.72) 0.66 (0.60-0.70)
PAID-Food problems 0.77 (0.73-0.80) 0.78 (0.75-0.81)
a Two-item measure; thus, a PAID-Lack of social support r=0.54a r=0.66a
correlation coefficient was WHO-5 0.84 (0.82—0.86) 0.85 (0.83-0.87)
computed (p<0.001 )
yet distinct, the PAID-5 correlated positively with scores 
on the other problem areas: PAID-5/treatment, r=0.64; 
PAID-5/food, r=0.61; PAID-5/social support, r=0.58 (all 
p values <0.001). Finally, in accordance with previous 
research on sex differences in diabetes-related distress [7], 
we found that women had a significantly higher mean score 
than men (women’s mean score=6.81, SD=5.27; men’s 
mean score=5.23, SD=4.74) on the PAID-5, (t [587] = 3.79, 
p<0.001, Cohen’s <7=0.32).
The five items retained from the analyses conducted with 
subsample 1 were subjected to an exploratory factor 
analysis (EFA) using subsample 2. In this context, the 
EFA was used to identify the number of possible factors 
reflected in the correlations among the five items. It was 
anticipated that, as all items focused on diabetes-related 
distress, a single factor would emerge. The data were not 
normally distributed (i.e. scale items were positively 
skewed). Thus, principal-axis factoring, a specific type of 
EFA, was employed. A one-factor solution was found 
(eigenvalue^.97), accounting for approximately 59.3% of 
the variance. Cronbach’s a was good (see Table 1 ), and the 
mean score was 6.22 (SD=4.62, range=0-20).
As was observed with subsample 1, scores on the PAID-5 
correlated negatively with scores on the WHO-5, r=-0.40, 
/?<0.001. Scores on the PAID-5 and problems related to 
treatment, food, and social support also were found to 
correlate significantly: PAID-5/freatment, r=0.60; PAID-5/ 
food, r=0.65; and PAID-5/social support, r=0.62 (all 
p values <0.001). Again, female participants obtained 
higher scores on the PAID-5 than male participants (women: 
mean score=7.14, SD=4.93; men: mean score=5.27, SD= 
4.06, t [546.10]=4.94, p<0.001, Cohen’s <7=0.41).
Diagnostic accuracy of the PAID-5 was established 
using receiver operating characteristic analysis with both 
subsamples. To evaluate the ability of the PAID-5 to 
‘diagnose’ high distress, a cut-off score of >33 on the 20 
item PAID was used [5]. Using the optimal cut-off score of 
>8 on the PAID-5, the AUC value was 0.97 (95% CI 0.96- 
0.98) in subsample 1 and 0.98 (95% CI 0.97—0.99) in 
subsample 2, while sensitivity was 95% and specificity was 
89% for each of the subsamples.
Single-item screening measure Based on its psychometric 
properties, Item 12 (‘Worrying about the future and the 
possibility of serious complications’), hereafter called 
PAID-1, appeared most suitable as a rapid screen for 
diabetes distress. For subsamples 1 and 2, scores on this 
item correlated significantly with the WHO-5, the 20 item 
PAID and with scores on the treatment, food, and social 
support subscales of the PAID. The same sex difference 
noted for the PAID-5 emerged, with women having 
significantly higher scores on this item in each subsample. 
When using a cut-off score of >33 on the 20 item PAID 
(5 ), the optimal cut-off score of >3 on the PAID-1 yielded 
AUC values of 0.87 (95% CI 0.84-0.90) and 0.86 (95% 
CI 0.82-0.89) for subsamples 1 and 2. Sensitivity and 
specificity values were (in order): 75% and 86% (subsam­
ple 1) and 74% and 86% (subsample 2).
Discussion
Our findings suggest that a five-item version of the PAID 
possesses good reliability and validity. The diagnostic 
accuracy of the scale was acceptable, achieving a sensitivity 
rate of 95% and a specificity rate of 89%. The PAID-1 
appears suitable for screening pinposes in clinical settings, 
with adequate validity and a diagnostic accuracy of around 
80%. However, a high score on this item should prompt the 
clinician to administer the longer (and more reliable) PAID-5 
(see ESM).
A major strength of the PAID-5 is that it takes less than 
1 min to complete, yet it has comparable ‘diagnostic’ 
performance to the four-item Diabetes Distress Scale [9]. 
Both contain items assessing fear, depressed mood and the 
demands of living with diabetes; the PAID-1 focuses 
uniquely on concerns for the future, and this item is also 
included within the PAID-5.
Previous research has demonstrated that brief, verbally 
administered questions are effective at identifying depres­
sion in primary care [10]. Future research might seek to 
compare the effectiveness of verbal vs written administra­
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tion of the PAID-1, as well as its sensitivity to change 
following an intervention.
Additional psychometric testing of the PAID-5 and 
PAID-1 is required. However, the current study suggests 
that clinicians may now choose from more than one short­
form measure of diabetes-related emotional distress, with 
their choice of scale likely to depend on local practice and 
previous experience.
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